GCK Gene Hyperinsulinemic Hypoglycemia Type 3 Genetic Test
Test Name: GCK Gene Hyperinsulinemic Hypoglycemia Type 3 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for GCK Gene Hyperinsulinemic Hypoglycemia Type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinemic Hypoglycemia Type 3.
Test Details
The GCK gene is responsible for providing instructions to make an enzyme called glucokinase. Glucokinase plays a crucial role in regulating glucose levels in the body. Mutations in the GCK gene can lead to a condition called hyperinsulinemic hypoglycemia type 3 (HH3), which is characterized by low blood sugar levels.
NGS stands for next-generation sequencing, which is a high-throughput genetic testing method used to analyze multiple genes simultaneously. In the context of hyperinsulinemic hypoglycemia type 3, an NGS genetic test can be performed to identify mutations in the GCK gene that may be causing the condition.
This genetic test involves collecting a sample of DNA, typically through a blood sample or cheek swab, and then sequencing the DNA to identify any variations or mutations in the GCK gene. The results of the test can help diagnose hyperinsulinemic hypoglycemia type 3 and guide treatment decisions.
It is important to note that genetic testing should be performed by a qualified healthcare professional who can interpret the results and provide appropriate counseling and management options.
Test Name | GCK Gene Hyperinsulinemic hypoglycemia type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GCK Gene Hyperinsulinemic hypoglycemia type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hyperinsulinemic hypoglycemia type 3 |
Test Details |
The GCK gene is responsible for providing instructions to make an enzyme called glucokinase. Glucokinase plays a crucial role in regulating glucose levels in the body. Mutations in the GCK gene can lead to a condition called hyperinsulinemic hypoglycemia type 3 (HH3), which is characterized by low blood sugar levels. NGS stands for next-generation sequencing, which is a high-throughput genetic testing method used to analyze multiple genes simultaneously. In the context of hyperinsulinemic hypoglycemia type 3, an NGS genetic test can be performed to identify mutations in the GCK gene that may be causing the condition. This genetic test involves collecting a sample of DNA, typically through a blood sample or cheek swab, and then sequencing the DNA to identify any variations or mutations in the GCK gene. The results of the test can help diagnose hyperinsulinemic hypoglycemia type 3 and guide treatment decisions. It is important to note that genetic testing should be performed by a qualified healthcare professional who can interpret the results and provide appropriate counseling and management options. |